6-31170218-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002701.6(POU5F1):c.403G>A(p.Glu135Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002701.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU5F1 | NM_002701.6 | c.403G>A | p.Glu135Lys | missense_variant, splice_region_variant | 1/5 | ENST00000259915.13 | NP_002692.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU5F1 | ENST00000259915.13 | c.403G>A | p.Glu135Lys | missense_variant, splice_region_variant | 1/5 | 1 | NM_002701.6 | ENSP00000259915.7 | ||
POU5F1 | ENST00000441888.7 | c.-183-4171G>A | intron_variant | 1 | ENSP00000389359.2 | |||||
POU5F1 | ENST00000461401.1 | n.441G>A | splice_region_variant, non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000408 AC: 1AN: 245200Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134084
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460580Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726608
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 25, 2023 | The c.403G>A (p.E135K) alteration is located in exon 1 (coding exon 1) of the POU5F1 gene. This alteration results from a G to A substitution at nucleotide position 403, causing the glutamic acid (E) at amino acid position 135 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at